Bausch & Lomb (BLCO) Cash & Equivalents (2021 - 2026)

Bausch & Lomb (BLCO) has 6 years of Cash & Equivalents data on file, last reported at $268.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 32.67% year-over-year to $268.0 million; the trailing twelve-month figure through Mar 2026 stood at $268.0 million (up 32.67% YoY), and the FY2025 full-year result was $383.0 million, up 25.57% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $268.0 million, down from $383.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $437.0 million in Q2 2022 and bottomed at $190.0 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $315.0 million (2024), against an average of $314.5 million.
• The widest annual swing landed in 2022, when Cash & Equivalents soared 103.45%; it then sank 35.87% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $354.0 million in 2022, then dropped by 6.5% to $331.0 million in 2023, then fell by 7.85% to $305.0 million in 2024, then rose by 25.57% to $383.0 million in 2025, then slumped by 30.03% to $268.0 million in 2026.
• The last three Cash & Equivalents figures came in at $268.0 million (Q1 2026), $383.0 million (Q4 2025), and $310.0 million (Q3 2025), per Business Quant data.

Peer Comparison